Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, From L, Berwick M; Genes Environment and Melanoma Study Group. Begg CB, et al. Among authors: millikan rc. J Natl Cancer Inst. 2005 Oct 19;97(20):1507-15. doi: 10.1093/jnci/dji312. J Natl Cancer Inst. 2005. PMID: 16234564 Free article.
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma.
Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Berwick M; GEM Study Group. Begg CB, et al. Among authors: millikan rc. Int J Epidemiol. 2006 Jun;35(3):756-64. doi: 10.1093/ije/dyl044. Epub 2006 Mar 23. Int J Epidemiol. 2006. PMID: 16556646
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB; GEM Study Group. Berwick M, et al. Among authors: millikan rc. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1520-5. doi: 10.1158/1055-9965.EPI-06-0270. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896043
CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group. Orlow I, et al. Among authors: millikan rc. J Invest Dermatol. 2007 May;127(5):1234-43. doi: 10.1038/sj.jid.5700689. Epub 2007 Jan 11. J Invest Dermatol. 2007. PMID: 17218939 Free article.
Vitamin D receptor polymorphisms in patients with cutaneous melanoma.
Orlow I, Roy P, Reiner AS, Yoo S, Patel H, Paine S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Thomas NE, Gruber SB, Anton-Culver H, Rosso S, Gallagher RP, Dwyer T, Kanetsky PA, Busam K, From L, Begg CB, Berwick M; GEM Study Group. Orlow I, et al. Among authors: millikan rc. Int J Cancer. 2012 Jan 15;130(2):405-18. doi: 10.1002/ijc.26023. Epub 2011 Apr 25. Int J Cancer. 2012. PMID: 21365644 Free PMC article.
Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.
Mukherjee B, Delancey JO, Raskin L, Everett J, Jeter J, Begg CB, Orlow I, Berwick M, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Culver HA, Rosso S, Zanetti R, Kanetsky PA, From L, Gruber SB; GEM Study Investigators. Mukherjee B, et al. Among authors: millikan rc. J Natl Cancer Inst. 2012 Jun 20;104(12):953-6. doi: 10.1093/jnci/djs221. Epub 2012 Apr 24. J Natl Cancer Inst. 2012. PMID: 22534780 Free PMC article.
Familial aggregation of melanoma risks in a large population-based sample of melanoma cases.
Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick M; GEM Study Group. Begg CB, et al. Among authors: millikan rc. Cancer Causes Control. 2004 Nov;15(9):957-65. doi: 10.1007/s10522-004-2474-2. Cancer Causes Control. 2004. PMID: 15577298 Free article.
Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study.
Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Mujumdar U, Berwick M. Millikan RC, et al. Carcinogenesis. 2006 Mar;27(3):610-8. doi: 10.1093/carcin/bgi252. Epub 2005 Oct 29. Carcinogenesis. 2006. PMID: 16258177
Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, Berwick M. Kanetsky PA, et al. Among authors: millikan rc. Cancer Res. 2006 Sep 15;66(18):9330-7. doi: 10.1158/0008-5472.CAN-06-1634. Cancer Res. 2006. PMID: 16982779
190 results